Cromolyn Sodium

DRUG9 trials

Conditions

Autonomic Nervous System DiseasesCOVID-19 PneumoniaCOVID-19 Respiratory InfectionChronic Prostatitis With Chronic Pelvic Pain SyndromeDysautonomiaEnd Stage Renal DiseaseGastroesophageal RefluxHealthy

Early Phase 1

Mast Cells in Male Pelvic Pain and and Lower Urinary Tract Dysfunction

CompletedNCT03167216

Northwestern UniversityChronic Prostatitis With Chronic Pelvic Pain Syndrome

Start: 2017-08-01End: 2022-06-30Updated: 2024-12-18

Guanfacine and Cromolyn Sodium for POTS: The DBPOTS Trial

Not yet recruitingNCT07757555

Johns Hopkins UniversityAutonomic Nervous System Diseases, Dysautonomia, Orthostatic Intolerance +1

Start: 2026-08-15End: 2028-02-02Target: 25Updated: 2026-08-12

Phase 1

Cromolyn Detection of Silent Aspiration

TerminatedNCT01841307

University of California, San FranciscoGastroesophageal Reflux, Idiopathic Pulmonary Fibrosis, Lung Transplantation +1

Start: 2015-07-31End: 2017-09-30Updated: 2019-02-15

An Analysis of the Effect of Topical Cromolyn Sodium on Rosacea-associated Erythema

CompletedNCT01933464

University of California, San DiegoPapulopustular Rosacea

Start: 2013-08-31End: 2014-04-30Updated: 2019-08-07

Effect of Pre-Treatment With Cromolyn or Albuterol on Response to PUL-042 Inhalation Solution (PUL-042)

CompletedNCT02566252

Pulmotect, Inc.Healthy

Start: 2015-07-31End: 2016-03-31Updated: 2017-08-10

Inhaled Cromolyn Sodium in Patients With Locally Advanced Lung Cancer

Not yet recruitingNCT07675876

Carcinex IncLocally Advanced Non-Small Cell Lung Cancer, Lung Adenocarcinoma

Start: 2026-08-01End: 2027-08-01Target: 10Updated: 2026-07-01

Phase 2

Evaluating the Effect of Cromolyn Sodium in Uremic Pruritus

CompletedNCT00745199

Shiraz University of Medical SciencesEnd Stage Renal Disease, Pruritus

Start: 2008-05-31End: 2009-06-30Updated: 2009-08-18

Mast Cell Treatment in Post-tick Bite Illness (PTBI)

Not yet recruitingNCT07526558

University of North Carolina, Chapel HillMast Cell Stabilizer, Post-tick Bite Illness

Start: 2026-04-30End: 2027-01-01Target: 50Updated: 2026-04-13

Phase 3

Cromolyn Sodium for Treatment of COVID-19 Pneumonia

TerminatedNCT05077917

Texas Tech University Health Sciences Center, El PasoCOVID-19 Pneumonia, COVID-19 Respiratory Infection, Pneumonia, Viral